We willhaveexclusivityWe will openupinternationalsites forMino-Lok trialI'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamI won't diluteshareholdersWe expect tofinish theMino-Loktrial this yearAnymentionof Mino-WrapAn actualiMSCupdateThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetMyron Holubiakand I founded aprivatecompany in2013Our Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022Insidersinvested$26.5mMino-Lokpotentialmarket>$1BWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetHemorrhoidsis a $2BmarketWe had aphase 2btrial with100%efficacyThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Not manycompaniesthis size with2 late stageassetsI/ONTAK'spotentialmarket is>$300mWe willhaveexclusivityWe will openupinternationalsites forMino-Lok trialI'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamI won't diluteshareholdersWe expect tofinish theMino-Loktrial this yearAnymentionof Mino-WrapAn actualiMSCupdateThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetMyron Holubiakand I founded aprivatecompany in2013Our Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022Insidersinvested$26.5mMino-Lokpotentialmarket>$1BWe haveenough cashto go wellinto 2023I/ONTAKis our leadassetHemorrhoidsis a $2BmarketWe had aphase 2btrial with100%efficacyThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"Not manycompaniesthis size with2 late stageassetsI/ONTAK'spotentialmarket is>$300m

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. We will have exclusivity
  2. We will open up international sites for Mino-Lok trial
  3. I'm a shareholder myself
  4. Only biotech with 2 Myron's on the leadership team
  5. I won't dilute shareholders
  6. We expect to finish the Mino-Lok trial this year
  7. Any mention of Mino-Wrap
  8. An actual iMSC update
  9. There are no FDA approved drugs to treat hemorrhoids
  10. Mino-Lok is our lead asset
  11. Myron Holubiak and I founded a private company in 2013
  12. Our Halo-Lido trial will have final patient by end of 2022
  13. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  14. I/ONTAK was the best deal I ever made
  15. We intend to submit a BLA in 2H 2022
  16. Insiders invested $26.5m
  17. Mino-Lok potential market >$1B
  18. We have enough cash to go well into 2023
  19. I/ONTAK is our lead asset
  20. Hemorrhoids is a $2B market
  21. We had a phase 2b trial with 100% efficacy
  22. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  23. Not many companies this size with 2 late stage assets
  24. I/ONTAK's potential market is >$300m